Priya Sachdeva

Stock Analyst at UBS

(1.86)

# 3,013

Out of 4,836 analysts

4

Total ratings

50%

Success rate

3.61%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$320 → $330	$281.56	+17.20%	3	Apr 24, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$17.10	-0.58%	1	Jan 21, 2025

Penumbra

Apr 24, 2025

Maintains: Buy

Price Target: $320 → $330

Current: $281.56

Upside: +17.20%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $17.10

Upside: -0.58%